Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 10737 - 10744 of 12142 results
Employers Should File Their H-1B Visa Petitions by April 1st, 2014
February 18, 2014| Blog| Viewpoint
NLRB and Wal-Mart Face Off Over Strikes
February 18, 2014| Blog| Viewpoint
FTC Approves Another COPPA Safe Harbor Program
February 18, 2014| Blog| Viewpoint
Notice to Plans and PBMs: Pay for Contraceptive Services and Maybe We Will Pay You Back
February 18, 2014| Blog| Viewpoint
Some Valentine's Day Reading for Employers Trying to Manage Workplace Romances
February 14, 2014| Blog| Viewpoint
New Payment Card Technology Finally Coming to US? Target Takes the Lead
February 14, 2014| Blog| Viewpoint
Are Anti-Poaching Agreements Enforceable in New York? Not in the Absence of a Protectable Interest Says One New York Federal Court.
February 13, 2014| Blog| Viewpoint
NIST Framework for Critical Infrastructure Released
February 13, 2014| Blog| Viewpoint
News & Press Releases
Mintz Advises Point72 and Tsunami Express Car Wash in Acquisition of 53 Car Wash Locations from Whistle Express Car Wash
September 16, 2025
Mintz advised Point72 and Tsunami Express Car Wash, its portfolio company, in Tsunami’s acquisition of 53 car wash locations from Whistle Express Car Wash, which is owned by affiliates of Oaktree Capital Management.
Mintz Advises Charlesbank Capital Partners on Acquisition of Q6 Cyber
September 15, 2025
Mintz Advises on LB Pharmaceuticals’ $285 Million Initial Public Offering
September 12, 2025
Mintz advised the underwriters in connection with a $285 million initial public offering by LB Pharmaceuticals Inc of 19,000,000 shares of common stock at an initial public offering price of $15.00 per share. The aggregate gross proceeds to LB Pharmaceuticals from this offering were approximately $285 million before deducting underwriting discounts and commissions and other offering expenses. In addition, LB Pharmaceuticals granted the underwriters a 30-day option to purchase up to an additional 2,850,000 shares of common stock at the initial public offering price, less underwriting discounts and commissions. The shares began trading on the Nasdaq Global Market on September 11, 2025 under the ticker symbol “LBRX.”
Events
Podcasts
Mintz On Air: Practical Policies – DEI Developments: The Proxy Problem
September 16, 2025| Podcast|
Mintz On Air: Practical Policies – Disparage Me Not
August 26, 2025| Podcast|
Mintz On Air: Practical Policies - Investigations Unscripted
August 12, 2025| Podcast|